diabettes, impaired glucose tolerance
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with untreated diabetes or impaired glucose tolerance 2) HbA1C 5.2~6.4% 3) Patients with untreated hypertension or dyslipidemia 4) Patients whose content is obtained in written form
Exclusion criteria
Exclusion criteria: 1) Patients with malignant hypertension or secondary hypertension 2) Diabetic patients requiring medical treatment 3) Pregnant and probably pregnant patients 4) patients with abnormal serum creatinin value 5) Patients with severe hepatic dysfunction 6) Patients who had myocardial infarction or apoplexy within 3 months before the satrt of the study or who are treated. 7) Patients with severe allergy or with treatment by steroid 8) Patients with pancreatitis or pasthistory of pancreatitis 9) Patients with malignacy 10) other patients judged as being inappropriate for the subjects of the study by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| following items before and 3 months after the introduction of home telemonitoring system 1 plasma glucose level, HbA1C 2 Urine alubumin excretion 3 Lipid levels 4 Blood pressure 5 Body weight, Body Mass Index 6 Diabetic complication 7 newly required medicine for diabetes, blood pressure, or dyslipidemia | — |
Countries
Japan
Contacts
Kanazawa University Kanazawa University Hospital